The company is a high-tech enterprise focusing on independent innovation, large-scale production, specialized marketing and high-quality clinical application of orthopedic surgical robots and related technologies. It is also the first in China and the fifth in the world to obtain a medical robot registration license. In 2020, Tianzhihang successfully listed on the IPO Science and Technology Innovation Board. Based on deep understanding and exploration of orthopedic clinical needs, the company is committed to using intelligent methods to reshape orthopedic surgery processes, integrate all relevant upstream and downstream technical elements, develop related technologies and products with orthopedic surgical robot systems as the core, build an intelligent orthopedic platform for orthopedic surgery, and promote the intelligent orthopedic surgery platform to become the infrastructure of the orthopedic industry to help doctors perform operations accurately, safely and efficiently, improve patients' quality of life, benefit patients, and lead orthopedic surgery into the era of robotic intelligent surgery. The target customers of the company's products and services are medical institutions. The products and services provided by the company to medical institutions mainly cover orthopedic surgical robots, supporting equipment and consumables, technical services, etc. Among them, orthopedic surgical robots are the company's core products. Corporate honors: Top Ten Innovation Achievements Award, G20 Engineering Innovation Leading Enterprise, National Science and Technology Progress Award, etc.
No Data